Navigation Links
C.R. Bard Settles Its Second Transvaginal Mesh Case in West Virginia Multidistrict Litigation, Notes Parker Waichman LLP

New York, New York (PRWEB) August 22, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that C.R. Bard has agreed to settle for an undisclosed amount the second trial regarding its Avaulta-branded vaginal mesh device, according to court documents. The trial began, and was settled on, the same date, Aug. 21, 2013, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Queen v. C.R. Bard Inc., Case No. 2:11-cv-00012).

The settlement occurs about one week after another federal jury awarded a total of $2 million in damages to a Georgia woman, having found that C.R. Bard Inc. had failed to warn of the potential dangers associated with its Avaulta-branded vaginal mesh device, according to court documents. On Thursday, Aug. 15, 2013, the jurors awarded the woman $250,000 in compensatory damages and $1.75 million in punitive damages. The trial had begun on July 29, in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Cisson v. C.R. Bard Inc., Case No. 2:11-cv-00195).

“While we don’t know the amount of the settlement this time, we are hopeful that it will sufficiently help this claimant get the medical attention she may require in the future,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “And since the allegations in the first two trials are similar to what many women are alleging in the pending litigations, we are optimistic that there is a light at the end of the tunnel for all of those claimants injured by these products.”

Thousands of transvaginal mesh lawsuits have been formulated into six MDLs pending in U.S. District Court for the Southern District of West Virginia. The list is comprised of Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2327; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325; In Re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2187; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation, MDL No. 2326; In Re: Coloplast Corp., Pelvic Support Systems Products Liability Litigation, MDL No. 2387; and In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440.

The U.S. Food and Drug Administration (FDA) reported on July 13, 2011, that the most common complications associated with transvaginal mesh may include:

  •     Mesh erosion through the vagina (also called exposure, extrusion, or protrusion)
  •     Pain
  •     Infection
  •     Bleeding
  •     Pain during sexual intercourse (dyspareunia)
  •     Organ perforation
  •     Urinary problems

The FDA also stated that complications linked to transvaginal mesh implants are “not rare” and warned that use of such devices may actually be more harmful compared to alternative methods for treating pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Law Firm of Garcia & Phan Settles Another "Pre-litigation Settlement" for Online Trademark/Copyright Infringement on Behalf of their Client CortiSLIM® International
2. Yasmin, Yaz Alleged Blood-Clotting Lawsuits Update: Resource4thePeople Reports Bayer Settles Nearly 5,000 Cases for $1 Billion and also now Settling Gall Bladder Cases
3. Southern District of New York Settles False Claims Act Case Against Multi-State Provider Group Servicing Medicare and Medicaid Patients
4. Donor Kidney Re-Used in Second Patient After Failing in First
5. Secondhand smoke continues to vex children with asthma
6. Many Asthmatic Kids Harmed by Secondhand Smoke: Study
7. UMD team gives drug dropouts a second chance
8. First, Second Kidney Transplants Have Similar Success: Study
9. Secondhand Smoke May Harm Heart Function
10. Study Ties Secondhand Smoke to Bladder Irritation in Kids
11. A second victim comes forward in the sexual assault charges filed against Dr. Mike Adam.
Post Your Comments:
(Date:11/26/2015)... TX (PRWEB) , ... November 26, 2015 , ... PRMA ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! ... “We wake up every day excited to rebuild lives and it’s an honor to ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, ... The new Q-Suite 6 platform is based on the latest Java Enterprise standards. By ... piece of software for many key components of the suite. Much of the suite ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Water For Empowerment ™ attracts volunteers together who want to combine talents ... women as key stakeholders in the process. The non-profit launched its first major ...
(Date:11/25/2015)... ... 2015 , ... Finnleo, a leader in the traditional and far-infrared sauna industry, ... far-infrared saunas. , For traditional saunas, Finnleo is offering 20% off ... and Finnleo uses only European Grade A Nordic White Spruce from sustainably grown trees. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: